Al Henry, CEO, Keneric Healthcare stated, "Our decision to combine efforts with Angelini to further promote our RTD™ antimicrobial dressing will further increase the number of patients and practitioners that can experience RTD™s proven efficacy."
Todd Maddock, the CEO of Angelini U.S. stated, "We are excited to add Keneric's RTD Dressing to our product portfolio. We look to provide healthcare professionals and patients with a range of wound treatment options based on innovative technologies like Keneric's RTD™ Wound Dressing."
Keneric Healthcare is a medical device company, headquartered in Irving, Texas, that is recognized by healthcare executives and clinicians alike for the development of innovative products that improve care, increase clinician efficiency and streamline facility expenditures.
Angelini is a privately-held, mid-sized international manufacturer and marketer of pharmaceutical and healthcare products in the pharmaceutical, infection control, wound care, dialysis, and mass-market segments. Founded in Italy in 1919, the group has operations in 20 countries and employs 5,000 people.
If you would like more information about this topic, please call:
Keneric Healthcare - Adolph Escobedo at 972-666-4928
Angelini Pharma Inc. - Steven Adler at 800-726-2308
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/keneric-healthcare-and-angelini-pharma-partner-in-the-us-wound-care-market-300395455.html
SOURCE Angelini Pharma Inc.